← FDA DRUG APPROVALS

FDA ANDA · ANDA201518

DOXERCALCIFEROL

Sponsor: RISING

APPLICATION
ANDA201518
TYPE
ANDA
ORIGINAL APPROVAL
2016-09-09
LATEST ACTION
2024-11-22
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

DOXERCALCIFEROLPrescription
DOXERCALCIFEROL 2.5MCG · CAPSULE · ORAL
DOXERCALCIFEROLPrescription
DOXERCALCIFEROL 0.5MCG · CAPSULE · ORAL
DOXERCALCIFEROLPrescription
DOXERCALCIFEROL 1MCG · CAPSULE · ORAL

Approval history

2024-11-22Labeling · Supplement 1 · standardAP
2016-09-09UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →